Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
7.49
+0.61 (8.87%)
At close: Jan 22, 2025, 4:00 PM
7.46
-0.03 (-0.40%)
After-hours: Jan 22, 2025, 5:20 PM EST
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of $2.95 billion as of January 22, 2025. Its market cap has increased by 22.75% in one year.
Market Cap
2.95B
Enterprise Value
2.58B
1-Year Change
22.75%
Ranking
Category
Stock Price
$7.49
Market Cap Chart
Since the IPO on April 16, 2021, Recursion Pharmaceuticals's market cap has increased from $2.92B to $2.95B, an increase of 1.21%. That is a compound annual growth rate of 0.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 2.71B | 1.78% |
| Dec 31, 2024 | 2.67B | 24.83% |
| Dec 29, 2023 | 2.14B | 46.15% |
| Dec 30, 2022 | 1.46B | -49.51% |
| Dec 31, 2021 | 2.89B | -0.82% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 668.44B |
| UnitedHealth Group | 483.14B |
| Johnson & Johnson | 356.69B |
| Novo Nordisk | 355.58B |
| AbbVie | 305.03B |
| Merck & Co. | 243.45B |
| Thermo Fisher Scientific | 219.20B |
| Intuitive Surgical | 215.18B |